Literature DB >> 32702096

Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease.

Ibrahim M Idris1, Akib Abba1, Jamil A Galadanci2, Sharfuddeen A Mashi3, Nafiu Hussaini4, Sagir Ahmed Gumel1, Arthur L Burnett5, Michael R DeBaun6.   

Abstract

Recurrent ischemic priapism is a common complication of sickle cell disease (SCD). We assessed the burden, characteristics, and types of priapism, including sexual dysfunction, in a cohort of men with and those without SCD, to test the hypothesis that sexual dysfunction is more prevalent in men with SCD. In Kano, Nigeria, we conducted a comparative cross-sectional survey that included 500 and 250 men 18 to 40 years of age, with and without SCD, respectively. The survey used the Priapism Questionnaire and the International Index of Erectile Function for sexual function assessment. All eligible participants approached for the study gave informed consent and were enrolled. Stuttering and major priapism were defined based on the average duration of priapism experiences that lasted ≤4 and >4 hours, respectively. The prevalence of priapism was significantly higher in men with SCD than in those without it (32.6% vs 2%; P < .001). Stuttering priapism accounted for 73.6% of the priapism episodes in men with SCD. Nearly 50% of the participants with SCD-related priapism had never sought medical attention for this complication. The majority of the men with SCD-related priapism used exercise as a coping mechanism. Priapism affected the self-image of the men with SCD, causing sadness, embarrassment, and fear. The percentage of the men with SCD who had erectile dysfunction was more than twofold higher than that of those without SCD who had erectile dysfunction (P = .01). The men with SCD had a higher prevalence of priapism and sexual dysfunction than the men without SCD.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32702096      PMCID: PMC7391159          DOI: 10.1182/bloodadvances.2020002062

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  16 in total

1.  Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study.

Authors:  A B Adeyoju; A B K Olujohungbe; J Morris; A Yardumian; D Bareford; A Akenova; O Akinyanju; K Cinkotai; P H O'Reilly
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

Review 2.  Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.

Authors:  Shruti Chaturvedi; Michael R DeBaun
Journal:  Am J Hematol       Date:  2016-01       Impact factor: 10.047

3.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

Authors:  R C Rosen; A Riley; G Wagner; I H Osterloh; J Kirkpatrick; A Mishra
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

Review 4.  Treating stuttering priapism.

Authors:  Pejman Kheirandish; Frank Chinegwundoh; Shailesh Kulkarni
Journal:  BJU Int       Date:  2011-10       Impact factor: 5.588

5.  Priapism in Homozygous Sickle Cell Disease: A 40-year Study of the Natural History.

Authors:  G Serjeant; I Hambleton
Journal:  West Indian Med J       Date:  2015-04-27       Impact factor: 0.171

Review 6.  Priapism: pathophysiology and the role of the radiologist.

Authors:  J E Halls; D V Patel; M Walkden; U Patel
Journal:  Br J Radiol       Date:  2012-09-06       Impact factor: 3.039

Review 7.  Priapism: pathogenesis, epidemiology, and management.

Authors:  Gregory A Broderick; Ates Kadioglu; Trinity J Bivalacqua; Hussein Ghanem; Ajay Nehra; Rany Shamloul
Journal:  J Sex Med       Date:  2010-01       Impact factor: 3.802

Review 8.  Pathophysiology of priapism: dysregulatory erection physiology thesis.

Authors:  Arthur L Burnett
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

9.  Treatments for priapism in boys and men with sickle cell disease.

Authors:  Francis I Chinegwundoh; Sherie Smith; Kofi A Anie
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06

10.  Prevalence of Priapism and Its Awareness amongst Male Homozygous Sickle Cell Patients in Lagos, Nigeria.

Authors:  Adewumi Adediran; Kikelomo Wright; Akinsegun Akinbami; Adedoyin Dosunmu; Olajumoke Oshinaike; Bodunrin Osikomaiya; Sarah Ajibola; Kamal Ismail; Ebele Uche; Olaitan Ojelabi
Journal:  Adv Urol       Date:  2013-07-15
View more
  3 in total

1.  PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE-PART II.

Authors:  Michael R Debaun
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

Review 2.  Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Authors:  Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

3.  Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial.

Authors:  Peter Hsu; James C Gay; Chyongchiou J Lin; Mark Rodeghier; Michael R DeBaun; Robert M Cronin
Journal:  Blood Adv       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.